Free Trial

Samantha Semenkow Analyst Performance

Analyst at Citigroup

Samantha Semenkow is a stock analyst at Citigroup in the medical sector, covering 8 publicly traded companies. Over the past year, Samantha Semenkow has issued 9 stock ratings, including buy and hold recommendations. While full access to Samantha Semenkow's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Samantha Semenkow's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
9 Last 0 Years
Buy Recommendations
88.89% 8 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.9%8 ratings
Hold11.1%1 ratings
Sell0.0%0 ratings

Out of 9 total stock ratings issued by Samantha Semenkow at Citigroup, the majority (88.9%) have been Buy recommendations, followed by 11.1% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
6 companies
NYSE
25.0% of companies on NYSE
2 companies

Samantha Semenkow, an analyst at Citigroup, currently covers 8 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
100.0%

Samantha Semenkow of Citigroup specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
7 companies
87.5%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
12.5%

Samantha Semenkow's Ratings History at Citigroup

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biohaven Ltd. stock logo
BHVN
Biohaven
9/17/2025Initiated Coverage$13.52$28.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
9/2/2025Initiated Coverage$11.93$16.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
7/16/2025Initiated Coverage$7.71$16.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
5/27/2025Reiterated Rating$1.29$1.50Neutral
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
5/16/2025Lower Price Target$1.77$13.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
5/15/2025Lower Price Target$1.07$4.00Buy
argenex SE stock logo
ARGX
argenex
5/9/2025Boost Price Target$567.57$803.00Buy
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
5/2/2025Initiated Coverage$27.33$60.00Buy
argenex SE stock logo
ARGX
argenex
4/17/2025Boost Price Target$594.76$796.00Buy